Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06181266 |
| Title | A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1) |
| Acronym | PARADIGM-1 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Prokarium Ltd |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Michael G. Oefelein Clinical Trials | Bakersfield | California | 93301 | United States | Details | |
| Duke Health-Duke Cancer Center | Durham | North Carolina | 27710 | United States | Details | |
| Carolina Urologic Research Center, LLC | Myrtle Beach | South Carolina | 29572 | United States | Details | |
| Urology San Antonio Medical Center | San Antonio | Texas | 78229 | United States | Details |